SAHPRA Drug Registration
End-to-end marketing authorization support for medicines, generics, biologics, and complementary products — including CTD/eCTD dossier preparation, SAHPRA liaison, and approval tracking.
Learn More
Comprehensive SAHPRA regulatory consulting for pharmaceuticals, medical devices, and cosmetics. Medwisdom helps you achieve compliant, fast, and sustainable market entry in South Africa.
South Africa is the most developed healthcare market on the African continent, regulated by the South African Health Products Regulatory Authority (SAHPRA). The country serves as a gateway to sub-Saharan Africa, offering a sophisticated regulatory framework, a large patient population, and strong institutional infrastructure.
Africa as a whole is the world's second-fastest-growing pharmaceutical market, projected to exceed USD 30 billion, driven by rising disease burden, expanding middle-class healthcare spending, and a heavy reliance on externally developed pharmaceutical products. For Indian generic manufacturers and global innovators alike, South Africa represents a strategic, high-growth opportunity with clear regulatory pathways.
Medwisdom Lifescience provides end-to-end SAHPRA regulatory consulting services — enabling you to file dossiers efficiently, navigate complex compliance requirements, and achieve first-cycle approval.
Get a Free Regulatory AssessmentUnderstanding SAHPRA's framework is critical for a successful market entry strategy.
Our structured approach ensures a compliant, efficient, and first-cycle-friendly SAHPRA submission for your pharmaceutical, medical device, or cosmetic product.
We assess your product profile, identify the applicable SAHPRA pathway, and conduct a comprehensive dossier gap analysis.
Our team compiles Module 1–5 documentation in CTD format, including quality, non-clinical, and clinical data packages.
We submit the application, manage SAHPRA correspondence, respond to deficiency letters, and track approval timelines.
We handle variations, renewals, labelling updates, pharmacovigilance reporting, and ongoing regulatory compliance.
From initial market-entry strategy to post-approval lifecycle management, we provide complete regulatory support tailored to SAHPRA's requirements.
End-to-end marketing authorization support for medicines, generics, biologics, and complementary products — including CTD/eCTD dossier preparation, SAHPRA liaison, and approval tracking.
Learn MoreGuidance through Class A–D device licensing, conformity assessment, technical file preparation (STED format), and full SAHPRA registration lifecycle management.
Learn MorePreparation and submission of cosmetic notifications/registrations to SAHPRA, including ingredient compliance screening against restricted/prohibited lists and safety substantiation.
Learn MoreCompilation and submission of CTAs to SAHPRA and accredited ethics committees, including protocol support, investigator site compliance, and regulatory follow-up.
Learn MorePreparation of comprehensive safety and efficacy data packages, clinical evaluation reports (CERs), and performance studies for both drugs and medical devices per SAHPRA requirements.
Learn MoreComprehensive management of Type I/II variations, renewals, administrative amendments, and labelling updates for SAHPRA-registered products to maintain market authorization validity.
Learn MoreLocal pharmacovigilance system setup, adverse event and serious ADR reporting to SAHPRA, PSUR/PBRER submissions, signal detection, and risk management plan (RMP) development.
Learn MoreGuidance on SAHPRA GMP requirements, manufacturing site documentation, pre-inspection readiness, CAPA implementation, and GMP certification support for pharmaceutical manufacturers.
Learn MoreInternal QMS audits, ISO 13485 implementation support, ISO 14971 risk management file development, and SAHPRA inspection readiness for pharmaceutical and device manufacturers.
Learn MoreReview and optimization of product labelling, patient information leaflets (PILs), and IFUs to comply with SAHPRA's multilingual (11 official languages) and regulatory requirements.
Learn MoreSupport for SAHPRA import/export permits, Section 21 unregistered medicine authorizations, batch release documentation, and customs compliance for all regulated health products.
Learn MoreReview of all promotional materials, product claims, and digital advertising content to ensure full compliance with SAHPRA guidelines and South African advertising regulations.
Learn MoreAssistance with SAHPRA pharmacy establishment licensing, wholesale/distribution permits, and all related regulatory documentation required to operate in the South African market.
Learn MoreComplete compilation and submission of STED-aligned technical dossiers for medical devices and CTD/eCTD-format dossiers for medicines, ensuring SAHPRA format compliance from day one.
Learn MoreIngredient screening and compliance verification against SAHPRA prohibited/restricted substance lists for cosmetics, complementary medicines, and OTC products, including safety substantiation.
Learn MoreWe combine deep SAHPRA expertise, a proven track record, and a client-first approach to deliver results that matter — faster approvals, fewer deficiencies, and stronger market positions.
Specialized knowledge of SAHPRA regulations, African regulatory harmonization initiatives, and sub-Saharan market entry strategy.
Our team includes seasoned regulatory affairs professionals with hands-on SAHPRA dossier and submission experience across all product categories.
Proactive deficiency prevention, well-structured dossiers, and strong SAHPRA relationships help reduce review timelines and accelerate approvals.
From regulatory strategy to post-approval lifecycle management, we remain your single point of contact throughout your South Africa journey.
Every deliverable is prepared to meet SAHPRA standards, minimizing the risk of rejections, deficiency letters, or costly re-submissions.
Hundreds of successfully submitted and approved dossiers across African, European, and Middle Eastern regulatory jurisdictions.